DR. MURRAY BRENT STEIN, M.D., M.P.H.
Psychiatric at La Jolla Village Dr, San Diego, CA

License number
California C43195
Category
Psychiatric
Type
Psychiatry
Address
Address 2
3350 La Jolla Village Dr, San Diego, CA 92161
8950 Villa La Jolla Dr SUITE B-218, La Jolla, CA 92037
Phone
(619) 400-5199
(858) 534-6451
(858) 450-1491 (Fax)

Professional information

Murray B Stein Photo 1

Dr. Murray B Stein, San Diego CA - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Psychiatry)
Address:
200 W Arbor Dr, San Diego 92103
3350 La Jolla Village Dr, San Diego 92161
(619) 400-5199 (Phone)
Certifications:
Psychiatry, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Manitoba / Faculty of Medicine
U Manitoba
Natl Inst Mh
U Toronto
Nimh


Murray Stein Photo 2

First Officer At Scripps Institution Of Oceanography

Location:
Greater San Diego Area
Industry:
Research


Murray Stein Photo 3

Diagnosis Of Anxiety Disorders

US Patent:
2009020, Aug 20, 2009
Filed:
Nov 21, 2007
Appl. No.:
11/986553
Inventors:
Jordan W. Smoller - Newton MA, US
Martin P. Paulus - La Jolla CA, US
Joel Gelernter - New Haven CT, US
Murray B. Stein - La Jolla CA, US
International Classification:
C12Q 1/68, C07H 21/04, A61K 31/7088, A61P 25/24
US Classification:
514 44 A, 435 6, 536 243
Abstract:
The invention relates to methods for diagnosing a genetic predisposition or susceptibility for anxiety disorders in a human. The methods include detecting particular markers at the human RGS2 locus in a sample obtained from the human. The invention also relates to the improved diagnosis that is based on the analysis of haplotypes for the RGS2 locus.


Murray Stein Photo 4

Treatment Response In Generalized Social Phobia

US Patent:
2009022, Sep 3, 2009
Filed:
Feb 14, 2007
Appl. No.:
12/279178
Inventors:
Murray B. Stein - San Diego CA, US
Joel Gelernter - Woodbridge CT, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
This invention generally pertains to the field of psychiatry. In particular, this invention relates to, inter alia, the discovery that a subject's serotonin transporter gene promoter polymorphism genotype can be used to determine the subject's response to certain drug therapies.